| Synonyms: | |
| Status: | Approved (2021) |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | UYB6UOF69L |
| InChI Key | STPKWKPURVSAJF-LJEWAXOPSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C40H56N3O4S+ |
| Molecular Weight | 674.97 |
| AlogP | 6.62 |
| Hydrogen Bond Acceptor | 6.0 |
| Hydrogen Bond Donor | 1.0 |
| Number of Rotational Bond | 13.0 |
| Polar Surface Area | 70.08 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 3.0 |
| Heavy Atoms | 48.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Ileal bile acid transporter inhibitor | PubMed |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC10 family of sodium-bile acid co-transporters
|
- | 0 | - | - | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Liver Diseases | 2 | D008107 | ClinicalTrials |
| Biliary Atresia | 2 | D001656 | ClinicalTrials |
| Alagille Syndrome | 2 | D016738 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL363392 |
| DrugBank | DB16226 |
| FDA SRS | UYB6UOF69L |
| PubChem | 9831643 |
| SureChEMBL | SCHEMBL10013954 |